Upstream and downstream of mTOR
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Abstract
The evolutionarily conserved checkpoint protein kinase, TOR (target of rapamycin), has emerged as a major effector of cell growth and proliferation via the regulation of protein synthesis. Work in the last decade clearly demonstrates that TOR controls protein synthesis through a stunning number of downstream targets. Some of the targets are phosphorylated directly by TOR, but many are phosphorylated indirectly. In this review, we summarize some recent developments in this fast-evolving field. We describe both the upstream components of the signaling pathway(s) that activates mammalian TOR (mTOR) and the downstream targets that affect protein synthesis. We also summarize the roles of mTOR in the control of cell growth and proliferation, as well as its relevance to cancer and synaptic plasticity.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
The record
- Venue
- Genes & Development
- Topic
- PI3K/AKT/mTOR signaling in cancer
- Field
- Biochemistry, Genetics and Molecular Biology
- Canadian institutions
- McGill University
- Funders
- Canadian Institutes of Health ResearchNational Institutes of HealthHoward Hughes Medical Institute
- Keywords
- BiologyPI3K/AKT/mTOR pathwayEffectorCell biologyTOR signalingUpstream and downstream (DNA)PhosphorylationDownstream (manufacturing)Cell growthSignal transductionUpstream (networking)Genetics
- Has abstract in OpenAlex
- yes